Detail akcie Teleflex online

Business Summary: Teleflex Incorporated is a global provider of medical technology products. The Company offers a diverse portfolio of solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, the MANTA Vascular Closure device and Arrow OnControl powered bone biopsy system.
Financial Summary: BRIEF: For the three months ended 30 March 2025, Teleflex Inc revenues decreased 5% to $700.7M. Net income before extraordinary items increased from $15.7M to $95.1M. Revenues reflect Asia segment decrease of 12% to $73.8M, EMEA segment decrease of 5% to $151.2M. Net income reflects Unallocated expenses segment loss decrease of 47% to $84.4M, Americas segment income increase of 79% to $157.8M, EMEA segment income increase of 27% to $33.3M.